Therapy-, gender- and race-specific microRNA markers, target genes and networks related to glioblastoma recurrence and survival

Cancer Genomics and Proteomics

Volumn 8, Issue 4, 2011, Pages 173-183

  Delfino, K R ^a   Serao N V L ^a   Southey, B R ^a   Rodriguez Zas, S L ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Biomarkers; Clinical cohort; Gender; Glioblastoma; Hazard; MicroRNA; Race

Indexed keywords

MICRORNA;

ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CAUCASIAN; COHORT ANALYSIS; FEMALE; GENE TARGETING; GLIOBLASTOMA; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; SEX DIFFERENCE;

EID: 79960444234     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Novakova J, Slaby O, Vyzula R and Michalek J: MicroRNA involvement in glioblastoma pathogenesis. Biochem Biophys Res Commun 386(1): 1-5, 2009.
2. Wrensch M, Minn Y, Chew T, Bondy M and Berger MS: Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4(4): 278-299, 2002.
3. Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z and You Y: HsaMir-181a and Hsa-Mir-181b function as tumor suppressors in human glioma cells. Brain Res 1236: 185-193, 2008.
4. Chen G, Zhu W, Shi D, Lv L, Zhang C, Liu P and Hu W: MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting BCL-2. Oncol Rep 23(4): 997-1003, 2010.
5. Gaire RK, Bailey J, Bearfoot J, Campbell IG, Stuckey PJ and Haviv I: MIRAGAA-a methodology for finding coordinated effects of microRNA expression changes and genome aberrations in cancer. Bioinformatics 26(2): 161-167, 2010.
6. Zhou X, Kang C and Pu P: MicroRNA and brain tumors. Chin J Clin Oncol 4: 355-359, 2007.
7. Cui JG, Zhao Y, Sethi P, Li YY, Mahta A, Culicchia F and Lukiw WJ: Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), BMI-1 and E2F-3a, key regulators of brain cell proliferation. J Neurooncol 98(3): 297-304, 2010.
8. Cancer Genome Atlas Research Network: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216): 1061-1068, 2008.
9. TCGA. Available at: http://cancergenome.nih.gov/dataportal/.
10. Beehive. Available at: http://stagbeetle.animal.uiuc.edu/Beehive.
11. Chuang LY, Yang CS, Li JC and Yang CH: Chaotic genetic algorithm for gene selection and classification problems. OMICS 13(5): 407-420, 2009.
12. Chuang LY, Yang CH, Wu KC and Yang CH: A hybrid feature selection method for DNA microarray data. Comput Biol Med 41(4): 228-237, 2011.
13. Dumur CI, Ladd AC, Wright HV, Penberthy LT, Wilkinson DS, Powers CN, Garrett CT and DiNardo LJ: Genes involved in radiation therapy response in head and neck cancers. Laryngoscope 119(1): 91-101, 2009.
14. Li J and Tang X: A new classification model with simple decision rule for discovering optimal feature gene pairs. Comput Biol Med 37(11): 1637-1646, 2007. (Pubitemid 47364797)
15. Petrausch U, Martus P, Tonnies H, Bechrakis NE, Lenze D, Wansel S, Hummel M, Bornfeld N, Thiel E, Foerster MH and Keilholz U: Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases. Eye (Lond) 22(8): 997-1007, 2008.
16. Oyan AM, Bo TH, Jonassen I, Gjertsen BT, Bruserud O and Kalland KH: cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation. Int J Oncol 28(5): 1065-1080, 2006.
17. Grutzmann R, Boriss H, Ammerpohl O, Luttges J, Kalthoff H, Schackert HK, Kloppel G, Saeger HD and Pilarsky C: Metaanalysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes. Oncogene 24(32): 5079-5088, 2005. (Pubitemid 41129085)
18. Serão NVL, Delfino KR, Southey BR and Rodriguez-Zas SL: Development of a transcriptomic-based index to prognosticate cancer. In: Abstract Book of the 6th International Symposium on Bioinformatics Research and Applications 2010, 2010.
19. European Bioinformatics Institute. MicroCosm. Available at: http://www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5. Accessed June, 2010.
20. Griffiths-Jones S, Saini HK, van Dongen S and Enright AJ: miRBase: tools for microRNA genomics. Nucleic Acids Res 36(Database issue): D154-158, 2008.
21. Gene Ontology Consortium. The Gene Ontology in 2010: extensions and refinements. Nucleic Acids Res 38(Database issue): D331-335, 2010.
22. Kanehisa M and Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1): 27-30, 2000. (Pubitemid 30047706)
23. Al-Shahrour F, Minguez P, Tarraga J, Montaner D, Alloza E, Vaquerizas JM, Conde L, Blaschke C, Vera J and Dopazo J: BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments. Nucleic Acids Res 34(Web Server issue): W472-476, 2006.
24. BisoGenet. Available at: http://bio.cigb.edu.cu/bisogenet-cytoscape/.
25. Brennen C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A and Holland E: Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 4(11): e7752, 2009.
26. Wu C, Lin J, Hong M, Choudhury Y, Balani P, Leung D, Dang LH, Zhao Y, Zeng J and Wang S: Combinatorial control of suicide gene expression by tissue-specific promoter and microRNA regulation for cancer therapy. Mol Ther 17(12): 2058-2066, 2009.
27. Bandyopadhyay S, Mitra R, Maulik U and Zhang MQ: Development of the human cancer microRNA network. Silence 1(1): 6, 2010.
28. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C and Tuschl T: Identification of virus-encoded microRNAs. Science 304(5671): 734-736, 2004. (Pubitemid 38560879)
29. Taylor DD and Gercel-Taylor C: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110(1): 13-21, 2008. (Pubitemid 351853251)
30. Svoboda M, Izakovicova Holla L, Sefr R, Vrtkova I, Kocakova I, Tichy B and Dvorak J: Micro-RNAs miR125b and miR137 are frequently up-regulated in response to capecitabine chemoradiotherapy of rectal cancer. Int J Oncol 33(3): 541-547, 2008.
31. Yeung ML, Yasunaga J, Bennasser Y, Dusetti N, Harris D, Ahmad N, Matsuoka M and Jeang KT: Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res 68(21): 8976-8985, 2008.
32. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL, Jacob S and Majumder S: MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27 KIP1. J Biol Chem 283(44): 29897-29903, 2008.
33. Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A and Yakhini Z: Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS One 4(11): e8003, 2009.
34. Zhu ZL, Zhao ZR, Zhang Y, Yang YH, Wang ZM, Cui DS, Wang MW, Kleeff J, Kayed H, Yan BY and Sun XF: Expression and significance of FXYD-3 protein in gastric adenocarcinoma. Dis Markers 28(2): 63-69, 2010.
35. Akao Y, Nakagawa Y, Kitade Y, Kinoshita T and Naoe T: Down-regulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci 98(12): 1914-1920, 2007.
36. Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, Cai X, Wang K, Wang G, Ba Y, Zhu L, Wang J, Yang R, Zhang Y, Ren Z, Zen K, Zhang J and Zhang CY: Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28(10): 1385-1392, 2009.
37. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG: Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334(4): 1351-1358, 2005. (Pubitemid 41074723)
38. Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stuhler K, Meyer HE and Reifenberger G: Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol 20(3): 539-550, 2010.
39. Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, Fodstad O and Ju J: Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 28(46): 4065-4074, 2009.
40. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T and Holland EC: The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 23(11): 1327-1337, 2009.
41. Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang ZY, Sun HC and Wang XW: MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361(15): 1437-1447, 2009.
42. Jiang L, Mao P, Song L, Wu J, Huang J, Lin C, Yuan J, Qu L, Cheng SY and Li J: miR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol 177(1): 29-38, 2010.
43. Sasayama T, Nishihara M, Kondoh T, Hosoda K and Kohmura E: MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer 125(6): 1407-1413, 2009.
44. Zhu JY, Pfuhl T, Motsch N, Barth S, Nicholls J, Grasser F and Meister G: Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 83(7): 3333-3341, 2009.
45. George GP and Mittal RD: MicroRNAs: Potential biomarkers in cancer. Indian J Clin Biochem 25: 4-14, 2010.
46. Zhang C, Wang G, Kang C, Du Y and Pu P: Up-regulation of p27(KIP1) by miR-221/222 antisense oligonucleotides enhances the radiosensitivity of U251 glioblastoma. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 26(6): 634-638, 2009 (in Chinese).
47. Chan JA, Krichevsky AM and Kosik KS: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14): 6029-6033, 2005. (Pubitemid 40994386)
48. Mukand JA, Blackinton DD, Crincoli MG, Lee JJ and Santos BB: Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am J Phys Med Rehabil 80(5): 346-350, 2001.
49. Dorsam RT and Gutkind JS: G-Protein-coupled receptors and cancer. Nat Rev Cancer 7(2): 79-94, 2007.
50. Parker SL, Parker MS, Sah R and Sallee F: Angiogenesis and rhodopsin-like receptors: a role for N-terminal acidic residues? Biochem Biophys Res Commun 335(4): 983-992, 2005.
51. Chaudhry MA, Sachdeva H and Omaruddin RA: Radiation-induced micro-RNA modulation in glioblastoma cells differing in DNA-repair pathways. DNA Cell Biol 29(9): 553-561, 2010.
52. Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen TD, Lopes B, Schiff D, Purow B and Abounader R: MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 69(19): 7569-7576, 2009.
53. Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D and Xu L: Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 8: 266, 2008.
54. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, Bottoni A, Gasparini P, Harris CC, Visone R, Pekarsky Y, de la Chapelle A, Bloomston M, Dillhoff M, Rassenti LZ, Kipps TJ, Huebner K, Pichiorri F, Lenze D, Cairo S, Buendia MA, Pineau P, Dejean A, Zanesi N, Rossi S, Calin GA, Liu CG, Palatini J, Negrini M, Vecchione A, Rosenberg A and Croce CM: Reprogramming of miRNA networks in cancer and leukemia. Genome Res 20(5): 589-599, 2010.
55. Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Bcnkmann M and Haier J: Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol 16(8): 2339-2350, 2009.
56. Dong H, Siu H, Luo L, Fang X, Jin L and Xiong M: Investigating gene and microRNA expression in glioblastoma. BMC Genomics 11(Suppl 3): S16, 2010.
57. Guan Y, Mizoguchi M, Yoshimoto K, Hata N, Shono T, Suzuki SO, Araki Y, Kuga D, Nakamizo A, Amano T, Ma X, Hayashi K and Sasaki T: MiRNA-196 is up-regulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance. Clin Cancer Res 16(16): 4289-4297, 2010.
58. Stecca B, Ruiz I and Altaba A: Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. J Mol Cell Biol 2(2): 84-95, 2010.
59. Chen F, Zhu HH, Zhou LF, Wu SS, Wang J and Chen Z: Inhibition of c-FLIP expression by miR-512-3p contributes to taxol-induced apoptosis in hepatocellular carcinoma cells. Oncol Rep 23(5): 1457-1462, 2010.
60. Rauhala HE, Jalava SE, Isotalo J, Bracken H, Lehmusvaara S, Tammela TL, Oja H and Visakorpi T: miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer. Int J Cancer 127(6): 1363-1372, 2010.
61. Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A and Anderson B: Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One 4(7): e6229, 2009.
62. Samlos MA: Identification and Functional Analysis of Micro-RNAs Encoded by Kaposi's Sarcoma-associated Herpevirus. Case Western Reserve University, Ph.D. thesis, 2007.
63. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzó M and García-Foncillas J: Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29, 2006.
64. Wyman SK, Parkin RK, Mitchell PS, Fritz BR, O'Briant K, Godwin AK, Urban N, Drescher CW, Knudsen BS and Tewari M: Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS One 4(4): e5311, 2009.
65. Wurdinger T and Tannous BA: Glioma angiogenesis: Towards novel RNA therapeutics. Cell Adh Migr 3(2): 230-235, 2009.
66. Mokhtari T: Role of MicroRNAs in the Development of Cancer Stem Cells into Glioblastomas. 2008; Available at: http://realscience.breckschool.org/ upper/research/Research2008/Tara.pdf. Accessed June, 2010.
67. Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV and Renee R: Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 81(23): 12836-12845, 2007. (Pubitemid 350156921)